Semiconductor testing company Teradyne (NASDAQ:TER) missed analysts' expectations in Q4 FY2023, with revenue down 8.4% year on year to $670.6 million. Next quarter's revenue guidance of $565 million also underwhelmed, coming in 9.6% below analysts' estimates. It made a non-GAAP profit of $0.79 per share, down from its profit of $0.92 per share in the same quarter last year.
Is now the time to buy Teradyne? Find out by reading the original article on StockStory.
Teradyne (TER) Q4 FY2023 Highlights:
- Market Capitalization: $16.22 billion
- Revenue: $670.6 million vs analyst estimates of $677 million (0.9% miss)
- EPS (non-GAAP): $0.79 vs analyst estimates of $0.72 (10% beat)
- Revenue Guidance for Q1 2024 is $565 million at the midpoint, well below analyst estimates of $624.7 million (EPS guidance also well below)
- Free Cash Flow of $204.4 million, up 46.3% from the previous quarter
- Inventory Days Outstanding: 2, down from 96 in the previous quarter
- Gross Margin (GAAP): 56.6%, down from 57.5% in the same quarter last year
Sporting most major chip manufacturers as its customers, Teradyne (NASDAQ:TER) is a US-based supplier of automated test equipment for semiconductors as well as other technologies and devices.
Semiconductor ManufacturingThe semiconductor industry is driven by demand for advanced electronic products like smartphones, PCs, servers, and data storage. The need for technologies like artificial intelligence, 5G networks, and smart cars is also creating the next wave of growth for the industry. Keeping up with this dynamism requires new tools that can design, fabricate, and test chips at ever smaller sizes and more complex architectures, creating a dire need for semiconductor capital manufacturing equipment.
Sales GrowthTeradyne's revenue has been declining over the last three years, dropping by 3.6% on average per year. This quarter, its revenue declined from $731.8 million in the same quarter last year to $670.6 million. Semiconductors are a cyclical industry, and long-term investors should be prepared for periods of high growth followed by periods of revenue contractions (which can sometimes offer opportune times to buy).
Teradyne had a difficult quarter as revenue dropped 8.4% year on year, missing analysts' estimates by 0.9%. This could mean that the current downcycle is deepening.
Teradyne may be headed for an upturn. Although the company is guiding for a year-on-year revenue decline of 8.5% next quarter, analysts are expecting revenue to grow 11.1% over the next 12 months.
Product Demand & Outstanding InventoryDays Inventory Outstanding (DIO) is an important metric for chipmakers, as it reflects a business' capital intensity and the cyclical nature of semiconductor supply and demand. In a tight supply environment, inventories tend to be stable, allowing chipmakers to exert pricing power. Steadily increasing DIO can be a warning sign that demand is weak, and if inventories continue to rise, the company may have to downsize production.
This quarter, Teradyne's DIO came in at 2, which is 68 days below its five-year average. At the moment, these numbers show no indication of an excessive inventory buildup.
Key Takeaways from Teradyne's Q4 Results We were impressed by Teradyne's strong improvement in inventory levels. We were also excited its EPS outperformed Wall Street's estimates. However, revenue missed. Also, the company's revenue and EPS guidance for next quarter both missed analysts' expectations by a large amount. Management explained this, saying "Looking into the new year, we expect low tester utilization will impact demand in the first half of the year." Overall, this was a mixed quarter for Teradyne with guidance that was particularly bad. The company is down 6.7% on the results and currently trades at $97.5 per share.